Stocks and Investing Stocks and Investing
Fri, November 12, 2021
Thu, November 11, 2021
Wed, November 10, 2021
Tue, November 9, 2021

Marc Goodman Maintained (AXSM) at Buy with Decreased Target to $65 on, Nov 9th, 2021


Published on 2024-10-27 18:34:55 - WOPRAI, Marc Goodman
  Print publication without navigation


Marc Goodman of SVB Leerink, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Decreased Target from $75 to $65 on, Nov 9th, 2021.

Marc has made no other calls on AXSM in the last 4 months.



There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 1 agrees with Marc's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $34 on, Tuesday, August 10th, 2021


These are the ratings of the 3 analyists that currently disagree with Marc


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $180 on, Monday, August 30th, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $55 on, Tuesday, August 10th, 2021
  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $160 on, Tuesday, August 10th, 2021